Kenia Hoyos
Kenia Hoyos has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- William Hoyos
Grupo de Investigación ISI, Universidad Cooperativa de Colombia, Montería 230002, Colombia
5 shared publications - Erick Diaz-Morales
Salud Social Clinic, Sincelejo 700001, Sucre, Colombia
4 shared publications - Nerlis Pajaro-Castro
Medical and Pharmaceutical Sciences Group, Faculty of Health Sciences, University of Sucre, Sincelejo 700001, Sucre, Colombia
3 shared publications - Rander Ruíz
Universidad de Antioquia, Colombia
3 shared publications - Salim Mattar
Universidad de Córdoba
2 shared publications - Bethia Pacheco
Departamento de Epidemiología, Fundación Universitaria del Área Andina, Bogotá 110211, Colombia
1 shared publication
Latest Publications
- Open Access
- 4 February 2026
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 94 (1) , 14
Virtual Screening Targeting LasR and Elastase of Pseudomonas aeruginosa Followed by In Vitro Antibacterial Evaluation
Pseudomonas aeruginosa is a Gram-negative pathogen with a remarkable capacity to acquire multiple resistance mechanisms, severely limiting current therapeutic options. Consequently, the identification of new antimicrobial agents remains a critical priority. In this study, an integrated in silico-guided strategy was applied to identify small molecules with antibacterial potential against P. aeruginosa, targeting the quorum-sensing regulator LasR (PDB ID: 2UV0) and elastase (PDB ID: 1U4G). Pharmacophore modeling was performed for both targets, followed by ligand-based virtual screening, structure-based virtual screening (SBVS), and MM-GBSA (Molecular Mechanics-Generalized Born Surface Area) binding free energy calculations. Top-ranked compounds based on predicted binding affinity were selected for in vitro cytotoxicity and antibacterial evaluation. Antimicrobial activity was assessed against three P. aeruginosa strains: an American Type Culture Collection (ATCC) reference strain, a clinically susceptible isolate, and an extensively drug-resistant (XDR) clinical isolate. SBVS yielded docking scores ranging from −6.96 to −12.256 kcal/mol, with MM-GBSA binding free energies between −18.554 and −88.00 kcal/mol. Minimum inhibitory concentration (MIC) assays revealed that MolPort-001-974-907, MolPort-002-099-073, MolPort-008-336-135, and MolPort-008-339-179 exhibited MIC values of 62.5 µg/mL against the ATCC strain, indicating weak-to-moderate antibacterial activity consistent with early-stage hit compounds. MolPort-008-336-135 showed the most favorable activity against the clinically susceptible isolate, with an MIC of 62.5 µg/mL, while maintaining HepG2 cell viability above 70% at this concentration and an half-maximal inhibitory concentration (IC50) greater than 500 µg/mL. In contrast, all tested compounds displayed MIC values above 62.5 µg/mL against the XDR isolate, reflecting limited efficacy against highly resistant strains. Overall, these results demonstrate the utility of in silico-driven approaches for the identification of antibacterial hit compounds targeting LasR and elastase, while highlighting the need for structure–activity relationship optimization to improve potency, selectivity, and activity against multidrug-resistant P. aeruginosa.
- 4 February 2026
- Published by MDPI AG in Scientia Pharmaceutica
- Vol. 94 (1) , 14
Open AccessVirtual Screening Targeting LasR and Elastase of Pseudomonas aeruginosa Followed by In Vitro Antibacterial Evaluation
Pseudomonas aeruginosa is a Gram-negative pathogen with a remarkable capacity to acquire multiple resistance mechanisms, severely limiting current therapeutic options. Consequently, the identification of new antimicrobial agents remains a critical priority. In this study, an integrated in silico-guided strategy was applied to identify small molecules with antibacterial potential against P. aeruginosa, targeting the quorum-sensing regulator LasR (PDB ID: 2UV0) and elastase (PDB ID: 1U4G). Pharmacophore modeling was performed for both targets, followed by ligand-based virtual screening, structure-based virtual screening (SBVS), and MM-GBSA (Molecular Mechanics-Generalized Born Surface Area) binding free energy calculations. Top-ranked compounds based on predicted binding affinity were selected for in vitro cytotoxicity and antibacterial evaluation. Antimicrobial activity was assessed against three P. aeruginosa strains: an American Type Culture Collection (ATCC) reference strain, a clinically susceptible isolate, and an extensively drug-resistant (XDR) clinical isolate. SBVS yielded docking scores ranging from −6.96 to −12.256 kcal/mol, with MM-GBSA binding free energies between −18.554 and −88.00 kcal/mol. Minimum inhibitory concentration (MIC) assays revealed that MolPort-001-974-907, MolPort-002-099-073, MolPort-008-336-135, and MolPort-008-339-179 exhibited MIC values of 62.5 µg/mL against the ATCC strain, indicating weak-to-moderate antibacterial activity consistent with early-stage hit compounds. MolPort-008-336-135 showed the most favorable activity against the clinically susceptible isolate, with an MIC of 62.5 µg/mL, while maintaining HepG2 cell viability above 70% at this concentration and an half-maximal inhibitory concentration (IC50) greater than 500 µg/mL. In contrast, all tested compounds displayed MIC values above 62.5 µg/mL against the XDR isolate, reflecting limited efficacy against highly resistant strains. Overall, these results demonstrate the utility of in silico-driven approaches for the identification of antibacterial hit compounds targeting LasR and elastase, while highlighting the need for structure–activity relationship optimization to improve potency, selectivity, and activity against multidrug-resistant P. aeruginosa.
- Open Access
- 15 December 2025
- Published by MDPI AG in Informatics
- Vol. 12 (4) , 141
Combining Fuzzy Cognitive Maps and Metaheuristic Algorithms to Predict Preeclampsia and Intrauterine Growth Restriction
Preeclampsia (PE) and intrauterine growth restriction (IUGR) are obstetric complications associated with placental dysfunction, which represent a public health problem due to high maternal and fetal morbidity and mortality. Early detection is crucial for timely interventions. Therefore, this study proposes the development of models based on fuzzy cognitive maps (FCM) optimized with metaheuristic algorithms (particle swarm optimization (PSO) and genetic algorithms (GA)) for the prediction of PE and IUGR. The results showed that FCM-PSO applied to the PE dataset achieved excellent performance (accuracy, precision, recall, and F1-Score = 1.0). The FCM-GA model excelled in predicting IUGR with an accuracy and F1-Score of 0.97. Our proposed models outperformed those reported in the literature to predict PE and IUGR. Analysis of the relationships between nodes allowed for the identification of influential variables such as sFlt-1, sFlt-1/PlGF, and uterine Doppler parameters, in accordance with the pathophysiology of placental disorders. FCM optimized with PSO and GA offer a viable clinical alternative as a medical decision support system due to their ability to explore nonlinear relationships and interpretability of variables. In addition, they are suitable for scenarios where low computational resource consumption is required.
- 15 December 2025
- Published by MDPI AG in Informatics
- Vol. 12 (4) , 141
Open AccessCombining Fuzzy Cognitive Maps and Metaheuristic Algorithms to Predict Preeclampsia and Intrauterine Growth Restriction
Preeclampsia (PE) and intrauterine growth restriction (IUGR) are obstetric complications associated with placental dysfunction, which represent a public health problem due to high maternal and fetal morbidity and mortality. Early detection is crucial for timely interventions. Therefore, this study proposes the development of models based on fuzzy cognitive maps (FCM) optimized with metaheuristic algorithms (particle swarm optimization (PSO) and genetic algorithms (GA)) for the prediction of PE and IUGR. The results showed that FCM-PSO applied to the PE dataset achieved excellent performance (accuracy, precision, recall, and F1-Score = 1.0). The FCM-GA model excelled in predicting IUGR with an accuracy and F1-Score of 0.97. Our proposed models outperformed those reported in the literature to predict PE and IUGR. Analysis of the relationships between nodes allowed for the identification of influential variables such as sFlt-1, sFlt-1/PlGF, and uterine Doppler parameters, in accordance with the pathophysiology of placental disorders. FCM optimized with PSO and GA offer a viable clinical alternative as a medical decision support system due to their ability to explore nonlinear relationships and interpretability of variables. In addition, they are suitable for scenarios where low computational resource consumption is required.
- 18 November 2025
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- p. 215-221
Sepsis por Salmonella spp: un estudio descriptivo de los factores de riesgo y la resistencia antimicrobiana
Introducción: La infección por Salmonella es un grave problema de salud pública que puede provocar cuadros clínicos leves y algunos con complicaciones mortales. El objetivo de este estudio fue describir los factores de riesgo y la resistencia antimicrobiana en pacientes con sepsis por Salmonella. Materiales y métodos: Entre enero de 2019 y junio de 2024, se realizó un estudio descriptivo-retrospectivo en una clínica privada del Caribe colombiano en Sincelejo, Sucre. Se analizaron las historias clínicas de pacientes con hemocultivos positivos para Salmonella. Se incluyeron variables sociodemográficas, clínicas y resultados de la resistencia antimicrobiana. Resultados: Se identificaron un total de 18 casos, la edad media de los pacientes fue de 41,6 ± 27,6 años, con un rango entre 1-92 años. Las manifestaciones clínicas principales al ingreso fueron: diarrea (44,4%), fiebre (27,8%) y síntomas respiratorios (27,8%). Los factores de riesgo identificados con mayor frecuencia fueron insuficiencia renal crónica (27,8%), infección por VIH (27,8%), hipertensión arterial (22,2%) y lupus eritematoso sistémico (22,2%). La resistencia a los antimicrobianos fue baja. Discusión: Aunque son pocos los casos de sepsis por Salmonella, es importante conocer los factores de riesgo asociados y el perfil de resistencia a los antimicrobianos para establecer protocolos de tratamiento empírico y prevenir la aparición de cepas multirresistentes.
- 18 November 2025
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- p. 215-221
Sepsis por Salmonella spp: un estudio descriptivo de los factores de riesgo y la resistencia antimicrobiana
Introducción: La infección por Salmonella es un grave problema de salud pública que puede provocar cuadros clínicos leves y algunos con complicaciones mortales. El objetivo de este estudio fue describir los factores de riesgo y la resistencia antimicrobiana en pacientes con sepsis por Salmonella. Materiales y métodos: Entre enero de 2019 y junio de 2024, se realizó un estudio descriptivo-retrospectivo en una clínica privada del Caribe colombiano en Sincelejo, Sucre. Se analizaron las historias clínicas de pacientes con hemocultivos positivos para Salmonella. Se incluyeron variables sociodemográficas, clínicas y resultados de la resistencia antimicrobiana. Resultados: Se identificaron un total de 18 casos, la edad media de los pacientes fue de 41,6 ± 27,6 años, con un rango entre 1-92 años. Las manifestaciones clínicas principales al ingreso fueron: diarrea (44,4%), fiebre (27,8%) y síntomas respiratorios (27,8%). Los factores de riesgo identificados con mayor frecuencia fueron insuficiencia renal crónica (27,8%), infección por VIH (27,8%), hipertensión arterial (22,2%) y lupus eritematoso sistémico (22,2%). La resistencia a los antimicrobianos fue baja. Discusión: Aunque son pocos los casos de sepsis por Salmonella, es importante conocer los factores de riesgo asociados y el perfil de resistencia a los antimicrobianos para establecer protocolos de tratamiento empírico y prevenir la aparición de cepas multirresistentes.
- Open Access
Genomic Characterization of Extremely Antibiotic-Resistant Strains of Pseudomonas aeruginosa Isolated from Patients of a Clinic in Sincelejo, Colombia
Pseudomonas aeruginosa is an opportunistic pathogen classified as a priority and a great public health concern; therefore, this research focuses on the genomic characterization of extremely resistant strains of P. aeruginosa isolated from patients in a clinic in Sincelejo, Colombia. Seven strains were analyzed by whole genome sequencing using the Illumina NovaSeq platform, with a focus on the identification of resistance genes and virulence factors through the CARD and VFDB databases. An ANI (Average Nucleotide Identity) analysis was carried out to determine the genetic relationship between the strains, complemented by a phylogenomic analysis to place the strains in different evolutionary clades. The results revealed that six of the strains are of Colombian origin, while one strain (547256) belongs to the high-risk clone ST773, previously unidentified in Colombia. Genome size ranged from 6 to 7.4 Mbp, indicating differences in genetic content among strains. Phylogenomic analysis confirmed that five strains belong to a multidrug-resistant (MDR) group, while one strain (572897) showed high alignment with a laboratory strain, and strain 547256 was not associated with any specific clade. Clinically, 100% of strains showed carbapenem resistance, resistance genes, and virulence factors that make them difficult to treat. This study provides key insights into the genetic diversity and resistance patterns of P. aeruginosa in this region, underscoring the need to monitor high-risk clones and optimize therapeutic strategies.
Open AccessGenomic Characterization of Extremely Antibiotic-Resistant Strains of Pseudomonas aeruginosa Isolated from Patients of a Clinic in Sincelejo, Colombia
Pseudomonas aeruginosa is an opportunistic pathogen classified as a priority and a great public health concern; therefore, this research focuses on the genomic characterization of extremely resistant strains of P. aeruginosa isolated from patients in a clinic in Sincelejo, Colombia. Seven strains were analyzed by whole genome sequencing using the Illumina NovaSeq platform, with a focus on the identification of resistance genes and virulence factors through the CARD and VFDB databases. An ANI (Average Nucleotide Identity) analysis was carried out to determine the genetic relationship between the strains, complemented by a phylogenomic analysis to place the strains in different evolutionary clades. The results revealed that six of the strains are of Colombian origin, while one strain (547256) belongs to the high-risk clone ST773, previously unidentified in Colombia. Genome size ranged from 6 to 7.4 Mbp, indicating differences in genetic content among strains. Phylogenomic analysis confirmed that five strains belong to a multidrug-resistant (MDR) group, while one strain (572897) showed high alignment with a laboratory strain, and strain 547256 was not associated with any specific clade. Clinically, 100% of strains showed carbapenem resistance, resistance genes, and virulence factors that make them difficult to treat. This study provides key insights into the genetic diversity and resistance patterns of P. aeruginosa in this region, underscoring the need to monitor high-risk clones and optimize therapeutic strategies.
- Open Access
- 3 January 2025
- Published by MDPI AG in Medical Sciences
- Vol. 13 (1) , 6
Whole-Genome Sequencing of Resistance, Virulence and Regulation Genes in Extremely Resistant Strains of Pseudomonas aeruginosa
Background/Objectives: Pseudomonas aeruginosa is a clinically significant opportunistic pathogen, renowned for its ability to acquire and develop diverse mechanisms of antibiotic resistance. This study examines the resistance, virulence, and regulatory mechanisms in extensively drug-resistant clinical strains of P. aeruginosa. Methods: Antibiotic susceptibility was assessed using the Minimum Inhibitory Concentration (MIC) method, and whole-genome sequencing (WGS) was performed on the Illumina NovaSeq platform. Results: The analysis demonstrated a higher prevalence of virulence genes compared to resistance and regulatory genes. Key virulence factors identified included secretion systems, motility, adhesion, and biofilm formation. Resistance mechanisms observed comprised efflux pumps and beta-lactamases, while regulatory systems involved two-component systems, transcriptional regulators, and sigma factors. Additionally, phenotypic profiles were found to correlate with resistance genes identified through genotypic analysis. Conclusions: This study underscores the significant resistance and virulence of the clinical P. aeruginosa strains analyzed, highlighting the urgent need for alternative strategies to address infections caused by extensively drug-resistant bacteria.
- 3 January 2025
- Published by MDPI AG in Medical Sciences
- Vol. 13 (1) , 6
Open AccessWhole-Genome Sequencing of Resistance, Virulence and Regulation Genes in Extremely Resistant Strains of Pseudomonas aeruginosa
Background/Objectives: Pseudomonas aeruginosa is a clinically significant opportunistic pathogen, renowned for its ability to acquire and develop diverse mechanisms of antibiotic resistance. This study examines the resistance, virulence, and regulatory mechanisms in extensively drug-resistant clinical strains of P. aeruginosa. Methods: Antibiotic susceptibility was assessed using the Minimum Inhibitory Concentration (MIC) method, and whole-genome sequencing (WGS) was performed on the Illumina NovaSeq platform. Results: The analysis demonstrated a higher prevalence of virulence genes compared to resistance and regulatory genes. Key virulence factors identified included secretion systems, motility, adhesion, and biofilm formation. Resistance mechanisms observed comprised efflux pumps and beta-lactamases, while regulatory systems involved two-component systems, transcriptional regulators, and sigma factors. Additionally, phenotypic profiles were found to correlate with resistance genes identified through genotypic analysis. Conclusions: This study underscores the significant resistance and virulence of the clinical P. aeruginosa strains analyzed, highlighting the urgent need for alternative strategies to address infections caused by extensively drug-resistant bacteria.
- Open Access
- 27 May 2024
- Published by Instituto Tecnologico Metropolitano (ITM) in TecnoLógicas
- Vol. 27 (60) , e3061
Implementación de mapas cognitivos difusos con algoritmos genéticos para predecir diabetes mellitus tipo 2
La diabetes mellitus tipo 2 es una enfermedad crónica no transmisible, causada por un trastorno en el metabolismo de la glucosa, que provoca un aumento anormal de su concentración en la sangre. El diagnóstico tardío de esta enfermedad contribuye al aumento de las tasas de morbilidad y mortalidad a nivel mundial. El desarrollo de modelos basados en inteligencia artificial para la predicción de diabetes podría acelerar el diagnóstico. Por tanto, el objetivo del presente estudio fue implementar un modelo de predicción de diabetes mellitus tipo 2 basado en mapas cognitivos difusos entrenado con un algoritmo genético. La metodología empleada consistió en utilizar un conjunto de datos del Instituto Nacional de Diabetes y Enfermedades Digestivas y Renales de la población de indios PIMA, que contiene información demográfica y clínica de 768 pacientes. El 70 % de los datos se empleó para el entrenamiento y validación, y el 30 % restante se utilizó para las pruebas de rendimiento. El modelo de mapas cognitivos difusos puede predecir la enfermedad con un 99 % de exactitud, 98 % de precisión y recall de 100 %. Se concluye que el modelo presenta una buena capacidad para predecir y evaluar el comportamiento de las variables de interés en la diabetes mellitus tipo 2, mostrando su valor como herramienta de soporte en la identificación oportuna de la enfermedad y apoyo a la toma de decisiones por parte del profesional médico.
- 27 May 2024
- Published by Instituto Tecnologico Metropolitano (ITM) in TecnoLógicas
- Vol. 27 (60) , e3061
Open AccessImplementación de mapas cognitivos difusos con algoritmos genéticos para predecir diabetes mellitus tipo 2
La diabetes mellitus tipo 2 es una enfermedad crónica no transmisible, causada por un trastorno en el metabolismo de la glucosa, que provoca un aumento anormal de su concentración en la sangre. El diagnóstico tardío de esta enfermedad contribuye al aumento de las tasas de morbilidad y mortalidad a nivel mundial. El desarrollo de modelos basados en inteligencia artificial para la predicción de diabetes podría acelerar el diagnóstico. Por tanto, el objetivo del presente estudio fue implementar un modelo de predicción de diabetes mellitus tipo 2 basado en mapas cognitivos difusos entrenado con un algoritmo genético. La metodología empleada consistió en utilizar un conjunto de datos del Instituto Nacional de Diabetes y Enfermedades Digestivas y Renales de la población de indios PIMA, que contiene información demográfica y clínica de 768 pacientes. El 70 % de los datos se empleó para el entrenamiento y validación, y el 30 % restante se utilizó para las pruebas de rendimiento. El modelo de mapas cognitivos difusos puede predecir la enfermedad con un 99 % de exactitud, 98 % de precisión y recall de 100 %. Se concluye que el modelo presenta una buena capacidad para predecir y evaluar el comportamiento de las variables de interés en la diabetes mellitus tipo 2, mostrando su valor como herramienta de soporte en la identificación oportuna de la enfermedad y apoyo a la toma de decisiones por parte del profesional médico.
- Open Access
- 7 May 2024
- Published by Universidad de Cordoba in Revista MVZ Córdoba
- Vol. 29 (2) , e4041
Incremento de la Leptospirosis en Colombia: necesidad de un marco conceptual One Health para su mitigación
La leptospirosis, es una enfermedad zoonótica causada por bacterias del género Leptospira (1). Se estima que a nivel mundial cada año ocurren cerca de un millón de casos, con alrededor de 60.000 muertes (2). Colombia es el segundo país en las Américas, con la prevalencia más alta de leptospirosis (3). Desde 2007 en Colombia, la leptospirosis es un evento de notificación obligatoria (4). En el 2024, en el país se notificaron 8.823 casos, lo que representa un incremento del 12.9% en comparación con el año 2023 (5).
- 7 May 2024
- Published by Universidad de Cordoba in Revista MVZ Córdoba
- Vol. 29 (2) , e4041
Open AccessIncremento de la Leptospirosis en Colombia: necesidad de un marco conceptual One Health para su mitigación
La leptospirosis, es una enfermedad zoonótica causada por bacterias del género Leptospira (1). Se estima que a nivel mundial cada año ocurren cerca de un millón de casos, con alrededor de 60.000 muertes (2). Colombia es el segundo país en las Américas, con la prevalencia más alta de leptospirosis (3). Desde 2007 en Colombia, la leptospirosis es un evento de notificación obligatoria (4). En el 2024, en el país se notificaron 8.823 casos, lo que representa un incremento del 12.9% en comparación con el año 2023 (5).
- Top Cited PapersOpen Access
- 25 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 690
Supporting Malaria Diagnosis Using Deep Learning and Data Augmentation
Malaria is an infection caused by the Plasmodium parasite that has a major epidemiological, social, and economic impact worldwide. Conventional diagnosis of the disease is based on microscopic examination of thick blood smears. This analysis can be time-consuming, which is key to generate prevention strategies and adequate treatment to avoid the complications associated with the disease. To address this problem, we propose a deep learning-based approach to detect not only malaria parasites but also leukocytes to perform parasite/L blood count. We used positive and negative images with parasites and leukocytes. We performed data augmentation to increase the size of the dataset. The YOLOv8 algorithm was used for model training and using the counting formula the parasites were counted. The results showed the ability of the model to detect parasites and leukocytes with 95% and 98% accuracy, respectively. The time spent by the model to report parasitemia is significantly less than the time spent by malaria experts. This type of system would be supportive for areas with poor access to health care. We recommend validation of such approaches on a large scale in health institutions.- 25 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (7) , 690
Top Cited PapersOpen AccessSupporting Malaria Diagnosis Using Deep Learning and Data Augmentation
Malaria is an infection caused by the Plasmodium parasite that has a major epidemiological, social, and economic impact worldwide. Conventional diagnosis of the disease is based on microscopic examination of thick blood smears. This analysis can be time-consuming, which is key to generate prevention strategies and adequate treatment to avoid the complications associated with the disease. To address this problem, we propose a deep learning-based approach to detect not only malaria parasites but also leukocytes to perform parasite/L blood count. We used positive and negative images with parasites and leukocytes. We performed data augmentation to increase the size of the dataset. The YOLOv8 algorithm was used for model training and using the counting formula the parasites were counted. The results showed the ability of the model to detect parasites and leukocytes with 95% and 98% accuracy, respectively. The time spent by the model to report parasitemia is significantly less than the time spent by malaria experts. This type of system would be supportive for areas with poor access to health care. We recommend validation of such approaches on a large scale in health institutions. - Open Access
- 2 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (5) , 533
Using Computational Simulations Based on Fuzzy Cognitive Maps to Detect Dengue Complications
Dengue remains a globally prevalent and potentially fatal disease, affecting millions of people worldwide each year. Early and accurate detection of dengue complications is crucial to improving clinical outcomes and reducing the burden on healthcare systems. In this study, we explore the use of computational simulations based on fuzzy cognitive maps (FCMs) to improve the detection of dengue complications. We propose an innovative approach that integrates clinical data into a computational model that mimics the decision-making process of a medical expert. Our method uses FCMs to model complexity and uncertainty in dengue. The model was evaluated in simulated scenarios with each of the dengue classifications. These maps allow us to represent and process vague and fuzzy information effectively, capturing relationships that often go unnoticed in conventional approaches. The results of the simulations show the potential of our approach to detecting dengue complications. This innovative strategy has the potential to transform the way clinical management of dengue is approached. This research is a starting point for further development of complication detection approaches for events of public health concern, such as dengue.
- 2 March 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (5) , 533
Open AccessUsing Computational Simulations Based on Fuzzy Cognitive Maps to Detect Dengue Complications
Dengue remains a globally prevalent and potentially fatal disease, affecting millions of people worldwide each year. Early and accurate detection of dengue complications is crucial to improving clinical outcomes and reducing the burden on healthcare systems. In this study, we explore the use of computational simulations based on fuzzy cognitive maps (FCMs) to improve the detection of dengue complications. We propose an innovative approach that integrates clinical data into a computational model that mimics the decision-making process of a medical expert. Our method uses FCMs to model complexity and uncertainty in dengue. The model was evaluated in simulated scenarios with each of the dengue classifications. These maps allow us to represent and process vague and fuzzy information effectively, capturing relationships that often go unnoticed in conventional approaches. The results of the simulations show the potential of our approach to detecting dengue complications. This innovative strategy has the potential to transform the way clinical management of dengue is approached. This research is a starting point for further development of complication detection approaches for events of public health concern, such as dengue.
- Open Access
- 29 December 2023
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 43 (Sp. 3) , 110-121
Modelo de inteligencia artificial para la detección temprana de diabetes
Introducción. La diabetes es una enfermedad crónica que se caracteriza por el aumento de la concentración de la glucosa en sangre. Puede generar complicaciones que afectan la calidad de vida y aumentan los costos de la atención en salud. En los últimos años, las tasas de prevalencia y mortalidad han aumentado en todo el mundo. El desarrollo de modelos con gran desempeño predictivo puede ayudar en la identificación temprana de la enfermedad. Desarrollar un modelo basado en la inteligencia artificial para apoyar la toma de decisiones clínicas en la detección temprana de la diabetes. Materiales y métodos. Se llevó a cabo un estudio de corte transversal, utilizando un conjunto de datos que incluía edad, signos y síntomas de pacientes con diabetes y de individuos sanos. Se utilizaron técnicas de preprocesamiento para los datos. Posteriormente, se construyó el modelo basado en mapas cognitivos difusos. El rendimiento se evaluó mediante tres parámetros: exactitud, especificidad y sensibilidad. El modelo desarrollado obtuvo un excelente desempeño predictivo, con una exactitud del 95 %. Además, permitió identificar el comportamiento de las variables involucradas usando iteraciones simuladas, lo que proporcionó información valiosa sobre la dinámica de los factores de riesgo asociados con la diabetes. Los mapas cognitivos difusos demostraron ser de gran valor para la identificación temprana de la enfermedad y en la toma de decisiones clínicas. Los resultados sugieren el potencial de estos enfoques en aplicaciones clínicas relacionadas con la diabetes y respaldan su utilidad en la práctica médica para mejorar los resultados de los pacientes.
- 29 December 2023
- Published by Instituto Nacional de Salud (Colombia) in Biomédica
- Vol. 43 (Sp. 3) , 110-121
Open AccessModelo de inteligencia artificial para la detección temprana de diabetes
Introducción. La diabetes es una enfermedad crónica que se caracteriza por el aumento de la concentración de la glucosa en sangre. Puede generar complicaciones que afectan la calidad de vida y aumentan los costos de la atención en salud. En los últimos años, las tasas de prevalencia y mortalidad han aumentado en todo el mundo. El desarrollo de modelos con gran desempeño predictivo puede ayudar en la identificación temprana de la enfermedad. Desarrollar un modelo basado en la inteligencia artificial para apoyar la toma de decisiones clínicas en la detección temprana de la diabetes. Materiales y métodos. Se llevó a cabo un estudio de corte transversal, utilizando un conjunto de datos que incluía edad, signos y síntomas de pacientes con diabetes y de individuos sanos. Se utilizaron técnicas de preprocesamiento para los datos. Posteriormente, se construyó el modelo basado en mapas cognitivos difusos. El rendimiento se evaluó mediante tres parámetros: exactitud, especificidad y sensibilidad. El modelo desarrollado obtuvo un excelente desempeño predictivo, con una exactitud del 95 %. Además, permitió identificar el comportamiento de las variables involucradas usando iteraciones simuladas, lo que proporcionó información valiosa sobre la dinámica de los factores de riesgo asociados con la diabetes. Los mapas cognitivos difusos demostraron ser de gran valor para la identificación temprana de la enfermedad y en la toma de decisiones clínicas. Los resultados sugieren el potencial de estos enfoques en aplicaciones clínicas relacionadas con la diabetes y respaldan su utilidad en la práctica médica para mejorar los resultados de los pacientes.